Ergoteles’s Fusion Acquisition Corp. II Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant FSNB.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-18,170
Closed -$179K 2196
2022
Q3
$179K Hold
18,170
0.01% 1226
2022
Q2
$178K Hold
18,170
0.01% 1370
2022
Q1
$179K Hold
18,170
0.01% 1026
2021
Q4
$180K Hold
18,170
0.01% 1062
2021
Q3
$177K Hold
18,170
0.01% 1036
2021
Q2
$182K Hold
18,170
﹤0.01% 1309
2021
Q1
$180K Buy
+18,170
New +$181K 0.01% 694

Other funds holding FSNB.U

Ergoteles's FSNB.U Position: Q4 2022 in Review

Ergoteles sold out of Fusion Acquisition Corp. II Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant (FSNB.U) in Q4 2022, closing a stake of 18,170 shares — an estimated $179K sold.

Ergoteles first reported a position in FSNB.U in Q1 2021 and held it in 7 quarters. The position peaked at $182K in Q2 2021. 25 funds tracked by Wall St. Rank hold FSNB.U as of Q4 2022.

  • Ergoteles reported no remaining Fusion Acquisition Corp. II Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant position as of Q4 2022 after selling out during the quarter.
  • Ergoteles sold 18,170 Fusion Acquisition Corp. II Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant shares in Q4 2022, an estimated $179K.
  • Ergoteles first reported a position in Fusion Acquisition Corp. II Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant in Q1 2021 and held it in 7 quarters.
  • Ergoteles's Fusion Acquisition Corp. II Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant position peaked at $182K in Q2 2021.
  • 25 funds tracked by Wall St. Rank held Fusion Acquisition Corp. II Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant as of Q4 2022.

Based on Ergoteles's 13F filing for Q4 2022, filed 14 Feb 2023.